Rystiggo (rozanolixizumab-noli)

Adult Dosing .

Dosage forms:  INJ

Special Note

[formulation clarification]

Info: nonproprietary name = rozanolixizumab-noli

generalized myasthenia gravis

[<50 kg]

Dose: 420 mg SC qwk x6wk; Info: for anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positive pts; may give subsequent cycles based on clinical response >63 days from start of previous cycle

[50-99.9 kg]

Dose: 560 mg SC qwk x6wk; Info: for anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positive pts; may give subsequent cycles based on clinical response >63 days from start of previous cycle

[>100 kg]

Dose: 840 mg SC qwk x6wk; Info: for anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positive pts; may give subsequent cycles based on clinical response >63 days from start of previous cycle

renal dosing

[see below]

renal impairment: no adjustment

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.